Type 2 diabetes, PUFAs, and vitamin D: Their relation to inflammation

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Guadarrama López, Ana L ^a   Valdés Ramos, Roxana ^a   Martínez Carrillo, Beatríz E ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADIPOCYTOKINE; ADIPONECTIN; ARACHIDONIC ACID; COLECALCIFEROL; CYTOKINE; ERGOCALCIFEROL; FATTY ACID; FISH OIL; GLUCOSE; INCRETIN; INSULIN; INTERLEUKIN 1; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; GLUCOSE BLOOD LEVEL;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BROWN ADIPOSE TISSUE; CELL VOLUME; CYTOKINE PRODUCTION; DIABETIC PATIENT; DIAGNOSTIC TEST; DIET SUPPLEMENTATION; DRUG EFFICACY; FAMILY HISTORY; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLUCOTOXICITY; HEREDITY; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPOLYSIS; LIPOTOXICITY; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVERNUTRITION; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WHITE ADIPOSE TISSUE; ANALOGS AND DERIVATIVES; BLOOD; GENE EXPRESSION; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOLOGY;

ADIPOKINES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; INCRETINS; INFLAMMATION; INSULIN; INSULIN-SECRETING CELLS; VITAMIN D;

EID: 84897013501     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/860703     Document Type: Review

References (153)

1. WHO, World Health Statics. 2013, http://www.who.int/gho/publications/ world-health-statistics/EN-WHS2011-TOC.pdf
2. Bulló M., García-Lorda P., Salas-Salvadó J., Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. European Journal of Endocrinology 2002 146 3 325 331 2-s2.0-0036207644 (Pubitemid 34257642)
3. Calder P. C., n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003 38 4 343 352 2-s2.0-0037971463 10.1007/s11745-003-1068-y (Pubitemid 36724290)
4. Chokkalingam K., Tsintzas K., Norton L., Jewell K., Macdonald I. A., Mansell P. I., Exercise under hyperinsulinaemic conditions increases whole-body glucose disposal without affecting muscle glycogen utilisation in type 1 diabetes. Diabetologia 2007 50 2 414 421 2-s2.0-34447639245 10.1007/s00125-006- 0520-0
5. Holick M. F., Vitamin D deficiency in CKD: why should we care? American Journal of Kidney Diseases 2005 45 6 1119 1121 2-s2.0-20444421506 10.1053/j.ajkd.2005.04.015 (Pubitemid 40806527)
6. Holick M. F., Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. Southern Medical Journal 2005 98 10 1024 1027 2-s2.0-27644454006 10.1097/01.SMJ.0000140865.32054.DB (Pubitemid 41572206)
7. Moore C. E., Murphy M. M., Holick M. F., Vitamin D intakes by children and adults in the United States differ among ethnic groups. Journal of Nutrition 2005 135 10 2478 2485 2-s2.0-26444580754 (Pubitemid 41429611)
8. Grant W. B., Holick M. F., Benefits and requirements of vitamin D for optimal health: a review. Alternative Medicine Review 2005 10 2 94 111 2-s2.0-21344463548 (Pubitemid 40911119)
9. Raiten D. J., Picciano M. F., Vitamin D and health in the 21st century: bone and beyond. Executive summary. The American Journal of Clinical Nutrition 2004 80 6 1673S 1677S 2-s2.0-14644401522
10. Hidayat R. S., Setiati S., Soewondo P., The association between vitamin D deficiency and type 2 diabetes mellitus in elderly patients. Acta medica Indonesiana 2010 42 3 123 129 2-s2.0-79953304977
11. Chiu K. C., Chuang L.-M., Yoon C., The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Medical Genetics 2001 2, article 2 2-s2.0-0001837087 10.1186/1471-2350-2-2 (Pubitemid 38692954)
12. Bolland M. J., Chiu W. W., Davidson J. S., Grey A., Bacon C., Gamble G. D., Reid I. R., The effects of seasonal variation of 25-hydroxyvitamin D on diagnosis of vitamin D insufficiency. New Zealand Medical Journal 2008 121 1286 63 74 2-s2.0-59449097297
13. Tzotzas T., Papadopoulou F. G., Tziomalos K., Karras S., Gastaris K., Perros P., Krassas G. E., Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. Journal of Clinical Endocrinology and Metabolism 2010 95 9 4251 4257 2-s2.0-77956606549 10.1210/jc.2010-0757
14. Heideman W. H. N., Nierkens V., Stronks K., Middelkoop B. J. C., Twisk J. W., Verhoeff A. P., De Wit M., Snoek F. J., DiAlert: a lifestyle education programme aimed at people with a positive family history of type 2 diabetes and overweight, study protocol of a randomised controlled trial. BMC Public Health 2011 11 751 1 9 2-s2.0-80053349706 10.1186/1471-2458-11-751
15. Pickup J. C., Crook M. A., Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998 41 10 1241 1248 2-s2.0-0031720795 10.1007/s001250051058 (Pubitemid 28449093)
16. Kahn S. E., The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003 46 1 3 19 2-s2.0-0037283601 (Pubitemid 36237741)
17. Stumvoll M., Goldstein B. J., Van Haeften T. W., Type 2 diabetes: principles of pathogenesis and therapy. The Lancet 2005 365 9467 1333 1346 2-s2.0-17044386953 10.1016/S0140-6736(05)61032-X
18. Weyer C., Bogardus C., Mott D. M., Pratley R. E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Journal of Clinical Investigation 1999 104 6 787 794 2-s2.0-0032742992 (Pubitemid 29536364)
19. Mercurio V., Carlomagno G., Fazio V., Fazio S., Insulin resistance: is it time for primary prevention? World Journal of Cardiology 2012 4 1 1 7
20. Tébar-Massó F. J. E.-J., La Diabetes en la Práctica Clínica 2009 Madrid, Spain Editorial Panamericana
21. Van Haeften T. W., Pimenta W., Mitrakou A., Korytkowski M., Jenssen T., Yki-Jarvinen H., Gerich J. E., Disturbances in β -cell function in impaired fasting glycemia. Diabetes 2002 51 1 S265 S270 2-s2.0-0036311380 (Pubitemid 34761527)
22. Butler A. E., Janson J., Soeller W. C., Butler P. C., Increased β -cell apoptosis prevents adaptive increase in β -cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 2003 52 9 2304 2314 2-s2.0-0042822112 10.2337/diabetes.52.9.2304 (Pubitemid 37059501)
23. Laybutt D. R., Preston A. M., Åkerfeldt M. C., Kench J. G., Busch A. K., Biankin A. V., Biden T. J., Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007 50 4 752 763 2-s2.0-33847677975 10.1007/s00125-006-0590-z (Pubitemid 46355827)
24. Scheen A. J., Paquot N., Lefebvre P. J., Glucoxocity and lipotoxicity, two partners in the vicious circle of type 2 diabetes. Revue Medicale de Liege 1999 54 6 535 538 2-s2.0-0032811779 (Pubitemid 29336251)
25. Sivitz W. I., Lipotoxicity and glucotoxicity in type 2 diabetes: effects on development and progression. Postgraduate Medicine 2001 109 4 55 64 2-s2.0-0035053220
26. Kim J. W., Yoon K. H., Glucolipotoxicity in Pancreatic beta-Cells. Diabetes & Metabolism Journal 2011 35 5 444 450
27. Poitout V., Robertson R. P., Minireview: secondary β -cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002 143 2 339 342 2-s2.0-0036153256 10.1210/en.143.2.339 (Pubitemid 34107184)
28. Lotfy M. S., Singh J., Kalász H., Tekes K., Adeghate E., Medicinal chemistry and applications of incretins and DPP-4 inhibitors in the treatment of type 2 diabetes mellitus. Open Medicinal Chemistry Journal 2011 5 2 82 92 2-s2.0-80455131061 10.2174/1874104501105010082
29. Ishii H., Sato Y., Takei M., Nishio S., Komatsu M., Glucose-incretin interaction revisited. Endocrine Journal 2011 58 7 519 525 2-s2.0-79960995890 10.1507/endocrj.EJ11-0064
30. Fernández-Real J. M., El adipocito como Biomarcador. Endocrinología y Nutrición 2003 50 6 187 197
31. Maedler K., Sergeev P., Ris F., Oberholzer J., Joller-Jemelka H. I., Spinas G. A., Kaiser N., Halban P. A., Donath M. Y., Glucose-induced β cell production of IL-1 β contributes to glucotoxicity in human pancreatic islets. Journal of Clinical Investigation 2002 110 6 851 860 2-s2.0-0036738398 10.1172/JCI200215318
32. Donath M. Y., Størling J., Berchtold L. A., Billestrup N., Mandrup-Poulsen T., Cytokines and β -cell biology: from concept to clinical translation. Endocrine Reviews 2008 29 3 334 350 2-s2.0-43549093332 10.1210/er.2007-0033 (Pubitemid 351679703)
33. Böni-Schnetzler M., Thorne J., Parnaud G., Marselli L., Ehses J. A., Kerr-Conte J., Pattou F., Halban P. A., Weir G. C., Donath M. Y., Increased interleukin (IL)-1 β messenger ribonucleic acid expression in β -cells of individuals with type 2 diabetes and regulation of IL-1 β in human islets by glucose and autostimulation. Journal of Clinical Endocrinology and Metabolism 2008 93 10 4065 4074 2-s2.0-53749100698 10.1210/jc.2008-0396
34. Bays H., Mandarino L., DeFronzo R. A., Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. Journal of Clinical Endocrinology and Metabolism 2004 89 2 463 478 2-s2.0-1442352339 10.1210/jc.2003-030723 (Pubitemid 38269844)
35. Crook M., Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabetic Medicine 2004 21 3 203 207 2-s2.0-1542344902 10.1046/j.1464-5491.2003.01030.x (Pubitemid 38299611)
36. Liu S. J. M., Manson J. E., Buring J. E., Stampfer M. J., Willett W. C., Ridker P. M., Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women1-3. American Journal of Clinical Nutrition 2002 75 3 492 498 2-s2.0-0036178115 (Pubitemid 34174942)
37. Coppack S. W., Pro-inflammatory cytokines and adipose tissue. Proceedings of the Nutrition Society 2001 60 3 349 356 2-s2.0-0034880752 (Pubitemid 32772450)
38. Eguchi K., Manabe I., Oishi-Tanaka Y., Ohsugi M., Kono N., Ogata F., Yagi N., Ohto U., Kimoto M., Miyake K., Tobe K., Arai H., Kadowaki T., Nagai R., Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metabolism 2012 15 4 518 533 2-s2.0-84859449180 10.1016/j.cmet.2012.01.023
39. Seifarth C. C., Hinkmann C., Hahn E.-C., Lohmann T., Harsch I. A., Reduced frequency of peripheral dendritic cells in type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes 2008 116 3 162 166 2-s2.0-42049091860 10.1055/s-2007-990278 (Pubitemid 351518535)
40. Zhang K., Kaufman R. J., Chapter twenty identification and characterization of endoplasmic reticulum stress-induced apoptosis in vivo. Methods in Enzymology 2008 442 395 419 2-s2.0-52049110715 10.1016/S0076-6879(08) 01420-1
41. Berrou J., Fougeray S., Venot M., Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes. PLoS ONE 2013 8 4 e62418
42. Hopps E., Camera A., Caimi G., Polimorphonuclear leukocytes and diabetes mellitus. Minerva Medica 2008 99 2 197 202 2-s2.0-46649107322 (Pubitemid 351946155)
43. Hand W. L., Hand D. L., Vasquez Y., Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes Research and Clinical Practice 2007 76 1 44 50 2-s2.0-33846932567 10.1016/j.diabres.2006.07.015 (Pubitemid 46240352)
44. Bhattacharya S. K., Shastri S., Mahajan P., Madhu S. V., Tripathi A. K., Rauniar G. P., Das B. P., Paudel K. R., Polymorphonuclear leukocyte function in type-2 diabetes mellitus patients and its correlation with glycaemic control. Nepal Medical College Journal 2007 9 2 111 116 2-s2.0-35848961660
45. Rayaman P. R., Çevikbaş A., Demirtunç R., Şehirli A. Ö., Gürer Ü. S., The effect of some antibiotics on Polymorphonuclear Leukocyte (PMN) functions and PMN'S myeloperoxidase activity, glutathione and malondialdehyde levels of patients with type 2 diabetes mellitus in vitro. Journal of Marmara University Institute of Health Sciences 2013 3 4 200 207
46. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T. F. E., Dragun D., Skurk T., Hauner H., Blüher M., Unger T., Wolf A.-M., Knippschild U., Hombach V., Marx N., T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1304 1310 2-s2.0-46249117032 10.1161/ATVBAHA.108.165100
47. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
48. Miyara M., Sakaguchi S., Natural regulatory T cells: mechanisms of suppression. Trends in Molecular Medicine 2007 13 3 108 116 2-s2.0-33847415066 10.1016/j.molmed.2007.01.003 (Pubitemid 46341958)
49. Voet D. V., Pratt C J., Fundamentos de Bioquímica 2009 2nd Buenos Aires, Argentina Editorial Panamericana
50. Melo V. C. O., Bioquímica de los Procesos Metabólicos 2000 México, Mexico Editorial Reverté
51. Sprecher H., Braceo U. D., Deckelbaum R.J., Long chain fatty acid metabolism. Polyunsaturated Fatty Acids in Human Nutrition 1992 New York, NY, USA Raven Press 13 23
52. Vafeiadou K. W., Weech M., Sharma V., Yaqoob P., Todd S., Williams C. M., Jackson K. G., Lovegrove J. A., A review of the evidence for the effects of total dietary fat, saturated, monounsaturated and n-6 polyunsaturated fatty acids on vascular function, endothelial progenitor cells and microparticles. British Journal of Nutrition 2012 107 3 303 324 2-s2.0-84856262664 10.1017/S0007114511004764
53. Harbige L. S., Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proceedings of the Nutrition Society 1998 57 4 555 562 2-s2.0-0032199579 (Pubitemid 128737127)
54. Harbige L. S., Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 2003 38 4 323 341 2-s2.0-0038647764 10.1007/s11745-003-1067-z (Pubitemid 36724289)
55. Merzouk S. A., Saker M., Reguig K. B., Soulimane N., Merzouk H., Guermouche B., Berrouiguet A. Y., Hichami A., Narce M., Khan N. A., N-3 polyunsaturated fatty acids modulate in-vitro T cell function in type I diabetic patients. Lipids 2008 43 6 485 497 2-s2.0-49349106092 10.1007/s11745-008-3176-3
56. Alnajjar A., Chabane Sari D., Abuharfeil N., Hudaib M., Aburjai T., Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people. Prostaglandins Leukotrienes and Essential Fatty Acids 2006 74 6 347 356 2-s2.0-33744524949 10.1016/j.plefa.2006. 03.001 (Pubitemid 43816847)
57. Calder P. C., Dietary fatty acids and the immune system. Nutrition Reviews 1998 56 1, part 2 S70 S83 2-s2.0-0031890289 (Pubitemid 28069972)
58. Calder P. C., Symposium on "Lipids and the immune system". Dietary fatty acids and lymphocyte functions. Proceedings of the Nutrition Society 1998 57 4 487 502 2-s2.0-0032198018 (Pubitemid 128737119)
59. Calder P. C., Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Brazilian Journal of Medical and Biological Research 1998 31 4 467 490 2-s2.0-0031902546 (Pubitemid 28223707)
60. Meydani S. N., Lichtenstein A. H., Cornwall S., Goldin B. R., Rasmussen H., Dinarello C. A., Schaefer E. J., Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. Journal of Clinical Investigation 1993 92 1 105 113 2-s2.0-0027323508 (Pubitemid 23208986)
61. Endres S., Ghorbani R., Kelley V. E., Georgilis K., Lonnemann G., Van Der Meer J. W. M., Cannon J. G., Rogers T. S., Klempner M. S., Weber P. C., Schaefer E. J., Wolff S. M., Dinarello C. A., The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. The New England Journal of Medicine 1989 320 5 265 271 2-s2.0-0024489402 (Pubitemid 19045549)
62. Calder P. C., New evidence in support of the cardiovascular benefit of long-chain n-3 fatty acids. Italian Heart Journal 2003 4 7 427 429 2-s2.0-1542600246
63. Calder P. C., Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Brazilian Journal of Medical and Biological Research 2003 36 4 433 446 2-s2.0-0038734360 (Pubitemid 36592146)
64. Calder P. C., Effects of fatty acids and dietary lipids on cells of the immune system. Proceedings of the Nutrition Society 1996 55 1 127 150 2-s2.0-0030093514 (Pubitemid 126795328)
65. Yaqoob P., Calder P. C., n-3 polyunsaturated fatty acids and inflammation in the arterial wall. European Journal of Medical Research 2003 8 8 337 354 2-s2.0-1542751712
66. Suresh Y., Das U. N., Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of ω -3 fatty acids. Nutrition 2003 19 3 213 228 2-s2.0-0037373641 10.1016/S0899-9007(02)00855-9 (Pubitemid 36279459)
67. Suresh Y., Das U. N., Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of ω -6 fatty acids. Nutrition 2003 19 2 93 114 2-s2.0-0037321243 10.1016/S0899-9007(02)00856-0 (Pubitemid 36194469)
68. Oliver E. M., McGillicuddy F. C., Harford K. A., Reynolds C. M., Phillips C. M., Ferguson J. F., Roche H. M., Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. Journal of Nutritional Biochemistry 2011 23 9 1192 1200 2-s2.0-82255163836 10.1016/j.jnutbio.2011.06.014
69. Storlien L. H., Kraegen E. W., Chisholm D. J., Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987 237 4817 885 888 2-s2.0-0023240831 (Pubitemid 17128276)
70. Kabir M., Skurnik G., Naour N., Pechtner V., Meugnier E., Rome S., Quignard-Boulangé A., Vidal H., Slama G., Clément K., Guerre-Millo M., Rizkalla S. W., Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. American Journal of Clinical Nutrition 2007 86 6 1670 1679 2-s2.0-36849077566 (Pubitemid 350232182)
71. Mostad I. L., Bjerve K. S., Lydersen S., Grill V., Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes. European Journal of Clinical Nutrition 2008 62 3 419 429 2-s2.0-40549092344 10.1038/sj.ejcn.1602703 (Pubitemid 351356583)
72. Vessby B., Aro A., Skarfors E., Berglund L., Salminen I., Lithell H., The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 1994 43 11 1353 1357 2-s2.0-0028564934
73. Shah M., Adams-Huet B., Brinkley L., Grundy S. M., Garg A., Lipid, glycemic, and insulin responses to meals rich in saturated, cis-monounsaturated, and polyunsaturated (n-3 and n-6) fatty acids in subjects with type 2 diabetes. Diabetes Care 2007 30 12 2993 2998 2-s2.0-37149008441 10.2337/dc07-1026 (Pubitemid 350255231)
74. Waite J. L. N., Hart K., Robertson D., Badley E., Burton S., The impact of fish-oil supplements on insulin sensitivity. Journal of Human Nutrition and Dietetics 2008 21 4 402 403
75. Barre D. E., Mizier-Barre K. A., Griscti O., Hafez K., High dose flaxseed oil supplementation may affect fasting blood serum glucose management in human type 2 diabetics. Journal of Oleo Science 2008 57 5 269 273 2-s2.0-43149109723
76. Garg M. L., Blake R. J., Clayton E., Munro I. A., MacDonald-Wicks L., Singh H., Moughan P. J., Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II. European Journal of Clinical Nutrition 2007 61 11 1312 1317 2-s2.0-35748941343 10.1038/sj.ejcn.1602650 (Pubitemid 350048213)
77. de Luis D. A., Conde R., Aller R., Izaola O., Sagrado M. G., Castrillón J. L. P., Dueñas A., Romero E., Effect of omega-3 fatty-acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study. European Review for Medical and Pharmacological Sciences 2009 13 1 51 55 2-s2.0-63249113851
78. Holman R. R., Paul S., Farmer A., Tucker L., Stratton I. M., Neil H. A. W., Atorvastatin in factorial with omega-3 EE90 risk reduction in diabetes (AFORRD): a randomised controlled trial. Diabetologia 2009 52 1 50 59 2-s2.0-57249088952 10.1007/s00125-008-1179-5
79. Nomura S., Shouzu A., Omoto S., Inami N., Ueba T., Urase F., Maeda Y., Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. Journal of Atherosclerosis and Thrombosis 2009 16 2 83 90 2-s2.0-67549136395
80. Rizza S., Tesauro M., Cardillo C., Galli A., Iantorno M., Gigli F., Sbraccia P., Federici M., Quon M. J., Lauro D., Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis 2009 206 2 569 574 2-s2.0-70349410386 10.1016/j.atherosclerosis.2009.03.006
81. Stirban A., Nandrean S., Götting C., Tamler R., Pop A., Negrean M., Gawlowski T., Stratmann B., Tschoepe D., Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. American Journal of Clinical Nutrition 2010 91 3 808 813 2-s2.0-77749264445 10.3945/ajcn.2009.28374
82. Lopes N., Sousa B., Martins D., Gomes M., Vieira D., Veronese L. A., Milanezi F., Paredes J., Costa J. L., Schmitt F., Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions. BMC Cancer 2010 10, article 483 2-s2.0-77956478256 10.1186/1471-2407-10-483
83. Arnson Y., Amital H., Shoenfeld Y., Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Annals of the Rheumatic Diseases 2007 66 9 1137 1142 2-s2.0-34548150136 10.1136/ard.2007.069831 (Pubitemid 47309727)
84. Jones B. J., Twomey P. J., Issues with vitamin D in routine clinical practice. Rheumatology 2008 47 9 1267 1268 2-s2.0-50849138871 10.1093/rheumatology/ken301
85. Hu F. B., Manson J. E., Stampfer M. J., Colditz G., Liu S., Solomon C. G., Willett W. C., Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. The New England Journal of Medicine 2001 345 11 790 797 2-s2.0-0035856017 10.1056/NEJMoa010492
86. Lindström J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J. G., Hemiö K., Hämäläinen H., Härkönen P., Keinänen-Kiukaanniemi S., Laakso M., Louheranta A., Mannelin M., Paturi M., Sundvall J., Valle T. T., Uusitupa M., Tuomilehto J., Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. The Lancet 2006 368 9548 1673 1679 2-s2.0-33751366229 10.1016/S0140-6736(06)69701-8 (Pubitemid 46048554)
87. Pittas A. G., Lau J., Hu F. B., Dawson-Hughes B., Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 6 2017 2029 2-s2.0-34347266963 10.1210/jc.2007-0298 (Pubitemid 46997093)
88. Mathieu C., Gysemans C., Giulietti A., Bouillon R., Vitamin D and diabetes. Diabetologia 2005 48 7 1247 1257 2-s2.0-23944458275 10.1007/s00125-005-1802-7 (Pubitemid 41186086)
89. van Etten E., Mathieu C., Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. Journal of Steroid Biochemistry and Molecular Biology 2005 97 1-2 93 101 2-s2.0-27544499686 10.1016/j.jsbmb.2005.06.002 (Pubitemid 41546218)
90. Seshadri K. G. T., Rajendran A B., Role of vitamin D on diabetes. The Journal of Clinical Endocrinology and Metabolism 2011 1 2 47 56
91. Knekt P., Laaksonen M., Mattila C., Häkänen T., Marniemi J., Heliövaara M., Rissanen H., Montonen J., Reunanen A., Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008 19 5 666 671 2-s2.0-50549084247 10.1097/EDE.0b013e318176b8ad
92. Pittas A. G., Dawson-Hughes B., Li T., Van Dam R. M., Willett W. C., Manson J. E., Hu F., Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006 29 3 650 656 2-s2.0-33646475087 (Pubitemid 44115368)
93. Liu S., Song Y., Ford E. S., Manson J. E., Buring J. E., Ridker P. M., Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. Women. Diabetes Care 2005 28 12 2926 2932 2-s2.0-33644826159 10.2337/diacare.28.12.2926 (Pubitemid 43942926)
94. Kayaniyil S., Vieth R., Retnakaran R., Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010 33 6 1379 1381
95. Broder A. R., Tobin J. N., Putterman C., Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases. Arthritis Research and Therapy 2010 12 5, article R191 2-s2.0-77957804277 10.1186/ar3161
96. Pittas A. G., Harris S. S., Stark P. C., Dawson-Hughes B., The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007 30 4 980 986 2-s2.0-34147190196 10.2337/dc06-1994 (Pubitemid 46556596)
97. Shab-Bidar S., Neyestani T. R., Djazayery A., Eshraghian M.-R., Houshiarrad A., Gharavi A., Kalayi A., Shariatzadeh N., Zahedirad M., Khalaji N., Haidari H., Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Medicine 2011 9, article 125 2-s2.0-82055171984 10.1186/1741-7015-9-125
98. Nilas L., Christiansen C., Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. International Journal of Obesity 1984 8 5 407 411 2-s2.0-0021745288 (Pubitemid 15215948)
99. Sugden J. A., Davies J. I., Witham M. D., Morris A. D., Struthers A. D., Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabetic Medicine 2008 25 3 320 325 2-s2.0-40049088819 10.1111/j.1464-5491.2007.02360.x (Pubitemid 351322698)
100. Jorde R., Figenschau Y., Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. European Journal of Nutrition 2009 48 6 349 354 2-s2.0-69949159348 10.1007/s00394-009-0020-3
101. Zittermann A., Frisch S., Berthold H. K., Götting C., Kuhn J., Kleesiek K., Stehle P., Koertke H., Koerfer R., Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. American Journal of Clinical Nutrition 2009 89 5 1321 1327 2-s2.0-65549137566 10.3945/ajcn.2008.27004
102. von Hurst P. R., Stonehouse W., Coad J., Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. British Journal of Nutrition 2010 103 4 549 555 2-s2.0-77649219884 10.1017/S0007114509992017
103. de Boer I. H., Tinker L. F., Connelly S., Curb J. D., Howard B. V., Kestenbaum B., Larson J. C., Manson J. E., Margolis K. L., Siscovick D. S., Weiss N. S., Calcium plus vitamin D supplementation and the risk of incident diabetes in the women's health initiative. Diabetes Care 2008 31 4 701 707 2-s2.0-48649108658 10.2337/dc07-1829
104. 2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009 120 8 687 698 2-s2.0-69549116323 10.1161/CIRCULATIONAHA.109. 856070
105. Joergensen C., Gall M.-A., Schmedes A., Tarnow L., Parving H.-H., Rossing P., Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010 33 10 2238 2243 2-s2.0-78650318218 10.2337/dc10-0582
106. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
107. Tsui H., Paltser G., Chan Y., Dorfman R., Dosch H. M., 'Sensing' the link between type 1 and type 2 diabetes. Diabetes/Metabolism Research and Reviews 2011 27 8 913 918 2-s2.0-80855131172 10.1002/dmrr.1279
108. Bastard J.-P., Maachi M., Lagathu C., Kim M. J., Caron M., Vidal H., Capeau J., Feve B., Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network 2006 17 1 4 12 2-s2.0-33745896155
109. Arner P., Insulin resistance in type 2 diabetes-role of the adipokines. Current Molecular Medicine 2005 5 3 333 339 2-s2.0-18644365016 10.2174/1566524053766022 (Pubitemid 40663138)
110. Vettor R., Milan G., Rossato M., Federspil G., Review article: adipocytokines and insulin resistance. Alimentary Pharmacology and Therapeutics, Supplement 2005 22 supplement 2 3 10 2-s2.0-27644509152 (Pubitemid 41564373)
111. Trayhurn P. W., Wood I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004 92 3 347 355 2-s2.0-6944237757 10.1079/BJN20041213 (Pubitemid 40277057)
112. Gandhi H., Upaganlawar A., Balaraman R., Adipocytokines: the pied pipers. J Pharmacol Pharmacother 2010 1 1 9 17
113. Fantuzzi G., Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology 2005 115 5 911 920 2-s2.0-18144408371 10.1016/j.jaci.2005.02.023 (Pubitemid 40616201)
114. Sánchez-Muñoz F., García-Macedo R., Alarcón-Aguilar F., Cruz M., Adipocinas, tejido adiposo y su relación con células del sistema inmune. Gaceta Médica de México 2005 141 6 505 512
115. Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J.-P., Bortoluzzi M.-N., Moizo L., Lehy T., Guerre-Millo M., Marchand-Brustel Y. L., Lewin M. J. M., The stomach is a source of leptin. Nature 1998 394 6695 790 793 2-s2.0-0032552112 10.1038/29547 (Pubitemid 28391644)
116. Stehno-Bittel L., Intricacies of fat. Physical Therapy 2008 88 11 1265 1278 2-s2.0-55849084682 10.2522/ptj.20080034
117. Fain J. N., Madan A. K., Hiler M. L., Cheema P., Bahouth S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 5 2273 2282 2-s2.0-2042480671 10.1210/en.2003-1336 (Pubitemid 38535056)
118. Procaccini C., Lourenço E. V., Matarese G., La Cava A., Leptin signaling: a key pathway in immune responses. Current Signal Transduction Therapy 2009 4 1 22 30 2-s2.0-65449170377 10.2174/157436209787048711
119. Martín-Romero C., Santos-Alvarez J., Goberna R., Sánchez-Margalet V., Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cellular Immunology 2000 199 1 15 24 2-s2.0-0034628016 10.1006/cimm.1999.1594 (Pubitemid 30118591)
120. Matarese G., Lechler R. I., Leptin in intestinal inflammation: good and bad gut feelings. Gut 2004 53 7 921 922 2-s2.0-3042618748 10.1136/gut.2003. 037283 (Pubitemid 38824144)
121. de Rosa V., Procaccini C., Calì G., Pirozzi G., Fontana S., Zappacosta S., La Cava A., Matarese G., A key role of leptin in the control of regulatory T Cell proliferation. Immunity 2007 26 2 241 255 2-s2.0-33847312289 10.1016/j.immuni.2007.01.011 (Pubitemid 46329441)
122. Santos-Alvarez J., Goberna R., Sánchez-Margalet V., Human leptin stimulates proliferation and activation of human circulating monocytes. Cellular Immunology 1999 194 1 6 11 2-s2.0-0033602850 10.1006/cimm.1999.1490 (Pubitemid 29283971)
123. Sennello J. A. F., Fayad R., Pini M. E., Gove M. E., Ponemone V., Cabay R. J., Siegmund B., Dinarello C. A., Fantuzzi G., Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2008 105 23 8085 8090 2-s2.0-45849086124 10.1073/pnas.0804091105 (Pubitemid 351904712)
124. Löfgren P., Andersson I., Adolfsson B., Leijonhufvud B.-M., Hertel K., Hoffstedt J., Arner P., Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state. Journal of Clinical Endocrinology and Metabolism 2005 90 11 6207 6213 2-s2.0-27744585941 10.1210/jc.2005-0596 (Pubitemid 41606545)
125. Natali G. L. E., Pedro M., Fernando B., Adiponestina: una adipocitoquina con múltiples funciones protectoras. Acta Bioquíminca Clínica 4217 4233
126. Pérez-Mayorga M., El adipocito como órgano endócrino. Implicaciones fisilogicas y terapeuticas. Revue Médicale 2007 15 2 225 242
127. Moreno M. J., Martínez J. A., Tejido adiposo: órgano de almacenamiento y órgano secretor. Anales Sis San Navarra 2002 25 1 29 39 (Pubitemid 34467906)
128. Steppan C. M., Brown E. J., Wright C. M., Bhat S., Banerjee R. R., Dai C. Y., Enders G. H., Silberg D. G., Wen X., Wu G. D., Lazar M. A., A family of tissue-specific resistin-like molecules. Proceedings of the National Academy of Sciences of the United States of America 2001 98 2 502 506 2-s2.0-0035895201 10.1073/pnas.98.2.502 (Pubitemid 32105071)
129. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M. L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and
130. Arner P., Resistin: yet another adipokine tells us that men are not mice. Diabetologia 2005 48 11 2203 2205 2-s2.0-27744562461 10.1007/s00125-005-1956-3 (Pubitemid 41618907)
131. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes. Nature 2001 409 6818 307 312 2-s2.0-0035905758 10.1038/35053000 (Pubitemid 32151228)
132. Milan G., Granzotto M., Scarda A., Calcagno A., Pagano C., Federspil G., Vettor R., Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obesity Research 2002 10 11 1095 1103 2-s2.0-0037540732 (Pubitemid 135686650)
133. Rajala M. W., Obici S., Scherer P. E., Rossetti L., Adipose-derived resistin and gut-derived resistin-like molecule- β selectively impair insulin action on glucose production. Journal of Clinical Investigation 2003 111 2 225 230 2-s2.0-0037241112 10.1172/JCI200316521 (Pubitemid 36105921)
134. Kusminski C. M., McTernan P. G., Kumar S., Role of resistin in obesity, insulin resistance and Type II diabetes. Clinical Science 2005 109 3 243 256 2-s2.0-25144447626 10.1042/CS20050078 (Pubitemid 41337128)
135. Hug C., Lodish H. F., Visfatin: a new adipokine. Science 2005 307 5708 366 367 2-s2.0-12344327355 10.1126/science.1106933 (Pubitemid 40139968)
136. Jia S. H., Li Y., Parodo J., Kapus A., Fan L., Holstein O. D., Marshall J. C., Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. Journal of Clinical Investigation 2004 113 9 1318 1327 2-s2.0-2342650912 10.1172/JCI200419930 (Pubitemid 39069931)
137. Ognjanovic S., Bryant-Greenwood G. D., Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. American Journal of Obstetrics and Gynecology 2002 187 4 1051 1058 2-s2.0-0036795752 10.1067/mob.2002.126295 (Pubitemid 35178410)
138. Chen M.-P., Chung F.-M., Chang D.-M., Tsai J. C.-R., Huang H.-F., Shin S.-J., Lee Y.-J., Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2006 91 1 295 299 2-s2.0-30344471828 10.1210/jc.2005-1475 (Pubitemid 43069152)
139. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I., Visfatin: a protein secreted by visceral fat that Mimics the effects of insulin. Science 2005 307 5708 426 430 2-s2.0-19944433652 10.1126/science.1097243 (Pubitemid 40139988)
140. Mackay C. R., Chemokines: immunology's high impact factors. Nature Immunology 2001 2 2 95 101 2-s2.0-0035256994 10.1038/84298 (Pubitemid 33707925)
141. Zlotnik A., Yoshie O., Chemokines: a new classification system and their role in immunity. Immunity 2000 12 2 121 127 2-s2.0-0034144269 (Pubitemid 30398626)
142. Rossi D., Zlotnik A., The biology of chemokines and their receptors. Annual Review of Immunology 2000 18 217 242 2-s2.0-0034080318 10.1146/annurev.immunol.18.1.217 (Pubitemid 30365380)
143. Liles W. C., van Voorhis W. C., Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. Journal of Infectious Diseases 1995 172 6 1573 1580 2-s2.0-0028973392 (Pubitemid 3023456)
144. Recasens M., Ricart W., Fernández Real J., obesidad e inflamación. Revista de medicina de la Universidad de Navarra 2004 48 2 49 54
145. Ruan H., Hacohen N., Golub T. R., Van Parijs L., Lodish H. F., Tumor necrosis factor- α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor- B activation by TNF- α is obligatory. Diabetes 2002 51 5 1319 1336 2-s2.0-0036313033 (Pubitemid 34826596)
146. Böni-Schnetzler M., Boller S., Debray S., Bouzakri K., Meier D. T., Prazak R., Kerr-Conte J., Pattou F., Ehses J. A., Schuit F. C., Donath M. Y., Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 2009 150 12 5218 5229 2-s2.0-71949118923 10.1210/en.2009-0543
147. Marcano Y., Torcat J., Ayala L., Verdi B., Lairet C., Maldonado M., Funciones endocrinonas del tejido adiposo. Revisión. Revista Venezolana de Endocrinología y Metabolismo 2006 4 1 15 21
148. Aguilar-Salinas C. A., Adiposidad Abdominal como factor de riesgo para enfermedades Crónicas. Salud Pública de México 2007 49 311 316
149. Fontana L., Eagon J. C., Trujillo M. E., Scherer P. E., Klein S., Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007 56 4 1010 1013 2-s2.0-34047155003 10.2337/db06-1656 (Pubitemid 46525079)
150. Maedler K., Sergeev P., Ehses J. A., Mathe Z., Bosco D., Berney T., Dayer J.-M., Reinecke M., Halban P. A., Donath M. Y., Leptin modulates β cell expression of IL-1 receptor antagonist and release of IL-1 β in human islets. Proceedings of the National Academy of Sciences of the United States of America 2004 101 21 8138 8143 2-s2.0-2542541353 10.1073/pnas.0305683101 (Pubitemid 38698067)
151. + channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islet. Diabetes 2004 53 7 1706 1713 2-s2.0-3042825017 10.2337/diabetes.53.7.1706 (Pubitemid 38857028)
152. Stienstra R. J., Koenen L., van der Meer T., Tack C. J., The inflammasome-mediated caspase-1 activation controls apipocyte differentiation and insulin sensitivity. Cytokine 2010 48 6 134 139 10.1016/j.cmet.2010.11.011
153. Toda Y., Tsukada J., Misago M., Kominato Y., Auron P. E., Tanaka Y., Autocrine induction of the human pro-IL-1 β gene promoter by IL-1 β in monocytes. Journal of Immunology 2002 168 4 1984 1991 2-s2.0-0037083506 (Pubitemid 34135802)